In addition, the NF-κB pathway is abnormally activated in hematopoietic diseases (multiple myeloma and AML) accompanied by a wide range of inflammatory factors, which build a terrific tumor microenvironment to promote the development of blood tumors 45, 46. This evidence concerns the gene NFKB1 and hematopoietic and lymphoid system neoplasm.